Kinfo
Ekso Bionics Holdings, Inc. logo

Ekso Bionics Holdings, Inc.

EKSONASDAQHealthcare·US · USD
$18.59
-0.44 (-2.31%)
Prices as of October 9, 2026 · market closed

Price

Key statistics

Valuation
Market cap66.24M USD
Enterprise value44.24M USD
Trailing P/E-3.79
Forward P/E-62.11
PEG ratio-0.28
Price / sales3.29
Price / book4.65
Profitability
Gross margin50.16%
Operating margin-119.71%
Profit margin-91.37%
Return on assets-33.62%
Return on equity-107.62%
Income (TTM)
Revenue12.80M USD
Gross profit6.84M USD
EBITDA-11.00M USD
Net income-11.92M USD
Diluted EPS-$5.11
Rev. growth (YoY)-38.30%
Balance sheet
Total cash1.17M USD
Total debt4.64M USD
Debt / equity51.45
Current ratio1.63
Book value / share$2.54
Cash flow (TTM)
Operating cash flow-11.80M USD
Levered free cash flow-4.50M USD
Shares & price
Shares outstanding3.56M
Float2.24M
Held by institutions26.74%
Beta0.78
50-day MA$10.62
200-day MA$6.93
52-week high$30.00
52-week low$3.50
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-04-28-0.23-2.04−786.96%2026-03-110.570.51−10.53%2026-02-231.010.59−41.58%
About Ekso Bionics Holdings, Inc.

Ekso Bionics Holdings, Inc. is a pioneering robotics company specializing in the development and commercialization of powered exoskeletons, wearable robotic devices designed to enhance human mobility, strength, and endurance. Founded in 2005, Ekso Bionics primarily serves medical rehabilitation and industrial sectors by offering innovative technologies that enable individuals with lower extremity weakness or paralysis—such as those affected by spinal cord injuries, stroke, or multiple sclerosis—to stand and walk with assistance. Their product portfolio includes advanced exoskeleton systems like EksoNR for neurorehabilitation and Indego Personal for personal mobility, as well as industrial exoskeletons that support workers performing physically demanding tasks. The company integrates adaptive software and sensor technologies to provide customizable support and track patient progress, contributing significantly to advancements in human mobility and workplace injury reduction. Headquartered in Northern California, Ekso Bionics continues to lead in exoskeleton technology, merging robotics and healthcare to improve quality of life and worker capability worldwide.

Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Mr. Scott G. Davis
Employees
50
Headquarters
San Rafael, CA, United States

Frequently asked questions about Ekso Bionics Holdings, Inc.